Press release
Pharma IQ have announced their new Polymorphism & Crystallisation Award Session
The interactive session will explore cutting edge work from poster competition entrants from pharmaceutical companies and academia, providing an opportunity for attendees to share their thoughts on the latest research and get involved with lively discussions. All Poster Award finalists will also have the opportunity to create a podcast about their work which will be available on the conference website prior to the event. On the day, the winner of the Poster Award will be decided by the poster advisory panel and awarded a prize during the drinks reception taking place after the poster session.
For more information on how to enter the Poster Award session, please visit www.polyandcrys.com
IQPC has an established reputation for delivering the highest standard of industry specific conferences, seminars and internal training programmes. We aim to keep business executives up-to date with the forefront of their industries’ trends, technological developments and regulatory landscape.
IQPC Ltd
Anchor House
15-19 Britten Street
London SW3 3QL
Rachel Kenworthy
+44 (0)20 7368 9564
Rachel.kenworthy@iqpc.co.uk
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharma IQ have announced their new Polymorphism & Crystallisation Award Session here
News-ID: 115186 • Views: …
More Releases from IQPC UK
How will financial services regain public trust? In-depth report from the Custom …
There have been many casualties since the start of the economic crisis and financial services are yet to escape the tarnish of the global recession.
In the wake of increased negative feeling from consumers about financial service institutions, organisations are keen to regain customer trust and increase customer satisfaction and loyalty. Increasing amounts of data, rapidly evolving technology and rising customer expectations mean delivering a consistent and holistic customer…
Pharma IQ Publish Big Pharma Global Recession Report - 44.4% Fear Redundancy in …
In the wake of high profile staff cuts at multinational global pharmaceutical and biotech companies, leading industry network Pharma IQ conducted a large scale study into job stability and future prospects for the industry in 2012.
The results of the study have now been published in a 13 page special report entitled “Big Pharma Global Recession Report”.
Among the finding of the study which surveyed hundreds of professionals is the fact that…
More Releases for Polymorphism
Single Nucleotide Polymorphism (SNP) Genotyping Market Overview 2024-2033 - Tren …
The single nucleotide polymorphism (snp) genotyping market size has grown exponentially in recent years. It will grow from $8.48 billion in 2023 to $10.24 billion in 2024 at a compound annual growth rate (CAGR) of 20.7%. The growth in the historic period can be attributed to increasing research in genomics, rise in genetic disorders, growth in personalized medicine, expanding pharmaceutical industry, rising demand for molecular diagnostics.
The single nucleotide…
Explore Single Nucleotide Polymorphism (SNP) Genotyping Market Demand 2020 - 202 …
According to a new report published by Allied Market Research, titled, "World Single Nucleotide Polymorphism (SNP) Genotyping Market - Opportunities and Forecasts, 2019-2026"
The global market size of Single Nucleotide Polymorphism (SNP) Genotyping is $XX million in 2020 with XX CAGR, and it is expected to reach $XX million by the end of 2026 with a CAGR of XX% from 2020 to 2027.
Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/1464?utm_source=openpr&utm_medium=Niranjan
Key…
Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue, Opportunity, For …
Single Nucleotide Polymorphism (SNP) Genotyping are single base positions in the genome that shows natural variation within a population. Single Nucleotide Polymorphism (SNP) Genotyping is the most profuse form of genetic variation in the human beings, totaling to all most 90% of all the differences between distinct individuals. Single Nucleotide Polymorphism (SNP) Genotyping patterns are most likely to affect many human phenotypes. Single Nucleotide Polymorphism (SNP) Genotyping plays a crucial…
Single Nucleotide Polymorphism (SNP) Genotyping Market Value Share, Analysis and …
Single Nucleotide Polymorphism (SNP) Genotyping are single base positions in the genome that shows natural variation within a population. Single Nucleotide Polymorphism (SNP) Genotyping is the most profuse form of genetic variation in the human beings, totaling to all most 90% of all the differences between distinct individuals. Single Nucleotide Polymorphism (SNP) Genotyping patterns are most likely to affect many human phenotypes. Single Nucleotide Polymorphism (SNP) Genotyping plays a crucial…
Single Nucleotide Polymorphism Genotyping Market USD 4.1 Billion by 2020
The global single nucleotide polymorphism genotyping market is estimated to reach USD 4.1 Billion in 2020, growing at a CAGR of 22.3% from 2016 to 2020, according to a market research report Single Nucleotide Polymorphism Genotyping Market 2013-2020, published by iHealthcareAnalyst, Inc.
Visit the Single Nucleotide Polymorphism Genotyping Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/single-nucleotide-polymorphism-genotyping-market/
The global single nucleotide polymorphism genotyping market report provides market size (Revenue USD Million 2013 to 2020), market…
Europe Production Market Share of Single Nucleotide Polymorphism (SNP) Genotypin …
Europe Single Nucleotide Polymorphism (SNP) Genotyping Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020.
In the current competitive era, it is imperative to keep a track of the latest policies adopted by key companies operating in any market. This can help vendors, stakeholders, and clients form better decisions about the market. The study on the Europe Single Nucleotide Polymorphism…
